Abstract:Importance: The reprogramming of lipid metabolism is a significant feature of tumors, yet the circulating levels of fatty acids in lung cancer patients remain to be explored. Moreover, the association between fatty acid levels and related factors, including nutritional intake, tumor metabolism, and tumor immunity, has been rarely discussed. Objectives: To explore the differences in serum free fatty acids between lung cancer patients and healthy controls, and investigate the factors associated with this phenomenon. Design and participants: A case-control study enrolled 430 primary lung cancer patients and 430 healthy controls. The whole population had a medium [Q1, Q3] age of 48.0 [37.0, 58.9] years, with females comprising 56% of the participants. The absolute quantification of 27 serum free fatty acids (FFAs) was measured using a liquid chromatography–mass spectrometry (LC-MS/MS) detection. Data, including dietary intake, blood indicators, and gene expression of lung tissues, were obtained from questionnaires, blood tests, and RNA-sequencing. Statistical differences in FFA levels between lung cancer patients and healthy controls were investigated, and related contributing factors were explored. Results: Levels of 22 FFAs were significantly higher in lung cancer patients compared to those in healthy controls, with fold changes ranging from 1.14 to 1.69. Lung cancer diagnosis models built with clinical and FFA features yielded an area under the receiver operating characteristic curve (AUROC) of 0.830 (0.780–0.880). Total fatty acids (TFAs), monounsaturated fatty acids (MUFAs), and polyunsaturated fatty acids (PUFAs) showed no significant dietary–serum associations, indicating that the elevations might not be attributed to an excessive intake of relevant fatty acids from the diet. For RNA-sequencing of lung tissues, among the 68 lipid metabolism genes, 26 genes showed significant upregulation (FDR < 0.05), while 33 genes exhibited significant downregulation, indicating the involvement of the fatty acids in the tumor metabolism. Through joint analysis with immune cells and inflammatory factors in the blood, fatty acids might exert suppressing effects on tumor immunity. Conclusions: Lung cancer patients had elevated levels of serum free fatty acids compared to healthy individuals. The elevations might not be attributed to an excessive intake of relevant fatty acids from the diet but related to pathological factors of tumor metabolism and immunity. These findings will complement research on fatty acid metabolism of lung cancer and provide insights into potential intervention targets.

Independent Associations Between Blood Lipid Profiles and Lung Cancer Risk

Independent And Joint Associations Of Blood Lipids And Lipoproteins With Lung Cancer Risk In Chinese Males: A Prospective Cohort Study

Novel Application of the Traditional Lipid Ratios As Strong Risk Predictors of Nonsmall-Cell Lung Cancer Risk in a Chinese Population

Causal Association of Nonalcoholic Fatty Liver Disease with 22 Extrahepatic Cancers: A Mendelian Randomization Study.

The Association Between Blood Lipid And Breast Cancer Risk: Evidence Based On A Dose-Response Meta-Analysis Comprising 900,669 Participants.

Serum lipid levels, genetic risk, and lung cancer incidence: A large prospective cohort study

Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer

Blood Lipid Metabolic Profiles and Causal Links to Site-Specific Cancer Risks: A Mendelian Randomization Study

Elevated serum lipid level can serve as early signal for metastasis for Non-Small Cell Lung Cancer patients: A retrospective nested case-control study.

Association of Serum Lipids and Abnormal Lipid Score with Cancer Risk: a Population-Based Prospective Study.

Associations of serum lipid level with risk of gastric cancer: A longitudinal study over 8 years

Association Between Leptin and Risk of Lung Cancer

Association Of Total Cholesterol, Low-Density Lipoprotein Cholesterol, And Non-High-Density Lipoprotein Cholesterol With Atherosclerotic Cardiovascular Disease And Cancer In A Chinese Male Population

Lipids, cholesterols, statins and liver cancer: a Mendelian randomization study

Lipid-lowering drugs affect lung cancer risk via sphingolipid metabolism: a drug-target Mendelian randomization study

Combination of body mass index and oxidized low density lipoprotein receptor 1 in prognosis prediction of patients with squamous non-small cell lung cancer

Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC–Heidelberg cohort

Non-Specific Elevated Serum Free Fatty Acids in Lung Cancer Patients: Nutritional or Pathological?

High-density Lipoprotein Cholesterol is a Favorable Prognostic Factor and Negatively Correlated with C-reactive Protein Level in Non-Small Cell Lung Carcinoma.

Association of Serum Lipid Levels and Clinical Outcomes in Early Breast Cancer Patients

Circulating Markers of Cellular Immune Activation in Prediagnostic Blood Sample and Lung Cancer Risk in the Lung Cancer Cohort Consortium (LC3).